Skip to main content
. 2020 Jan 21;12(3):191–195. doi: 10.3892/mco.2020.1981

Table IV.

Median survival based on gender and CTC status.

    CTC detected CTC not detected
Sex Total Total (%) Survival (months) Total (%) Survival (months)
Female 18 14(43) 58a 4(12) 37a
Male 15 12(36) 38b 3(9) 21b

aSurvival was improved, although not significantly, in women positive for CTCs compared with men, P=0.43.

bIn women negative for CTCs survival was longer, compared to men, but this was notindicated to be significant, P=0.61. CTC, circulating tumour cells.